Preparing for International Prevention Trials Involving HIV-Infected Individuals in Care Settings (HPTN063)
This study is ongoing, but not recruiting participants.
Sponsor:
HIV Prevention Trials Network
Information provided by (Responsible Party):
HIV Prevention Trials Network
ClinicalTrials.gov Identifier:
NCT01264185
First received: December 14, 2010
Last updated: November 28, 2012
Last verified: November 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to conduct preparatory research needed to design a behavioral intervention to decrease sexual transmission risk behaviors in HIV-infected individuals in care and to determine whether a similar intervention structure can be used across various sexual risk groups and cultural settings.
| Condition |
|---|
|
HIV |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Preparing for International Prevention Trials Involving HIV-Infected Individuals in Care Settings |
Resource links provided by NLM:
Further study details as provided by HIV Prevention Trials Network:
Primary Outcome Measures:
- Establish baseline rates of sexual HIV transmission risk [ Time Frame: 1 year ] [ Designated as safety issue: No ]To establish baseline rates of sexual HIV transmission risk behavior in high risk HIV-infected individuals, and to observe the rates and patterns of behavior change over time
- Structure and content of a behavioral intervention for individuals with HIV [ Time Frame: 1 year ] [ Designated as safety issue: No ]To gather formative data on the potential structure and content of a behavioral intervention for individuals with HIV in care in international settings and to determine the best, culturally appropriate model for the intervention that will link prevention to care for HIV-infected individuals.
- Identify psychosocial and sociodemographic correlates of sexual risk-taking [ Time Frame: 1 year ] [ Designated as safety issue: No ]To examine potential psychosocial and sociodemographic correlates of sexual risk-taking in these individuals in order to help shape the content of an individualized behavioral intervention
Secondary Outcome Measures:
- Determine sexually transmitted infection(STI)prevalence and incidence [ Time Frame: 1 year ] [ Designated as safety issue: No ]Evaluate STI prevalence and incidence and investigate whether these biomarkers may be used to corroborate self-reported sexual behavior associated with potential transmission risks
Biospecimen Retention: Samples With DNA
Blood, genital fluids
| Enrollment: | 751 |
| Study Start Date: | April 2010 |
| Estimated Study Completion Date: | May 2013 |
| Estimated Primary Completion Date: | May 2013 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
| Asia--Thailand; S. America--Brazil |
| Africa--Zambia |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Asia (Thailand) and South America (Brazil)
- 100 heterosexual men,
- 100 heterosexual women,
- 100 Men having sex with men (MSM), and
- ~40 community members and stakeholders
Africa (Zambia)
- 100 heterosexual men,
- 100 heterosexual women,
- ~40 community members and stakeholders
Criteria
Inclusion Criteria:
- Men and women at least 18 years of age (Note: Pregnant and breast feeding women are allowed to enroll into the study)
- Documented evidence of HIV infection (HIV diagnosis performed outside of the trial is acceptable so long as local/country guidelines were followed in the testing)
- Receiving HIV/AIDS care (defined as at least two visits within 9 months of enrollment) in a formal health care setting (clinic or hospital)
- Reported history of sexual risk behavior in the previous 12 months, including: acquisition of a sexually transmitted infection, vaginal or anal intercourse without a condom, difficulty negotiating condom use, or non-disclosure of HIV status to an HIV-uninfected partner or partner of unknown HIV serostatus.
- NOTE: For the MSM population, we will enroll men who have sex with men, regardless of whether or not they also have sex with women
Exclusion Criteria:
- Anyone currently enrolled in another study that involves protocolized HIV risk reduction counseling (e.g. ACTG 5175 or HPTN 052) or any other prevention study
- Anyone having unprotected (i.e. without a condom) sex for the expressed purpose of conceiving
- Planning to relocate out of the area in the next year
- Any condition that, in the opinion of the Investigator of Record or designee, would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01264185
Locations
| Brazil | |
| Instituto de Pesquisa Clinicaq Evandro Chagas CRS | |
| Manguinhos, RJ, Brazil, 221045-900 | |
| Thailand | |
| Chiang Mai University AIDS CRS | |
| Chiang Mai, Thailand | |
| Zambia | |
| Matero Reference Clinic | |
| Lusaka, Zambia | |
Sponsors and Collaborators
HIV Prevention Trials Network
Investigators
| Study Chair: | Steve Safren, PhD | Fenway Community Health Center |
| Study Chair: | Ken Mayer, MD | Fenway Community Health Center |
| Principal Investigator: | Stewart Reid, MD, MPH | Centre for Infectious Disease Research in Zambia (CIDRZ) |
| Principal Investigator: | Ruth Friedman, MD | Instituto de Pesquisa Clincia Evandro Chagas (IPEC) Clinical Research Site (CRS) |
| Principal Investigator: | Kriengkrai Srithanaviboonchai, MD, MPH | Chiang Mai University AIDS CRS |
More Information
No publications provided
| Responsible Party: | HIV Prevention Trials Network |
| ClinicalTrials.gov Identifier: | NCT01264185 History of Changes |
| Other Study ID Numbers: | HPTN 063 |
| Study First Received: | December 14, 2010 |
| Last Updated: | November 28, 2012 |
| Health Authority: | Brazil: Ethics Committee Zambia: Ethics Committee Thailand: Ethics Committee |
ClinicalTrials.gov processed this record on May 23, 2013